Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 11 | 14 | 12 | 12 | 6 |
| Gross Profit | 11 | 14 | 12 | 12 | 6 |
| Operating Expenses | 25,475 | 25,158 | 32,787 | 34,977 | 31,622 |
| Operating Income | -25,464 | -25,144 | -32,775 | -34,965 | -31,616 |
| Interest Expense | 37 | 37 | 29 | 0 | 0 |
| Other Income | 888 | 794 | 855 | 740 | 796 |
| Pre-tax Income | -24,613 | -24,387 | -31,949 | -34,225 | -30,820 |
| Income Tax | -98 | -149 | -52 | -228 | -143 |
| Net Income Continuous | -24,515 | -24,238 | -31,897 | -33,997 | -30,677 |
| Net Income | $-24,515 | $-24,238 | $-31,897 | $-33,997 | $-30,677 |
| EPS Basic Total Ops | -0.30 | -0.29 | -0.39 | -0.41 | -0.38 |
| EPS Basic Continuous Ops | -0.30 | -0.29 | -0.39 | -0.41 | -0.38 |
| EPS Diluted Total Ops | -0.30 | -0.29 | -0.39 | -0.41 | -0.38 |
| EPS Diluted Continuous Ops | -0.30 | -0.29 | -0.39 | -0.41 | -0.38 |
| EBITDA(a) | $-23,730 | $-22,690 | $-31,381 | $-33,935 | $-30,705 |